Date | Time | Source | Announcement |
---|---|---|---|
02 May 2001 | 04:45 PM | Re Prilosec Patent | |
02 May 2001 | 03:45 PM | Research Update | |
02 May 2001 | 07:00 AM | Purchase of Own Securities | |
27 Apr 2001 | 11:21 AM | Result of AGM | |
26 Apr 2001 | 09:30 AM | Q1 Results - Part 2 of 2 | |
26 Apr 2001 | 09:30 AM | Q1 Results - Part 1 of 2 | |
25 Apr 2001 | 09:00 AM | Notice of Results | |
23 Apr 2001 | 09:17 AM | Stmnt re Lawsuit | |
30 Mar 2001 | 04:30 PM | Director Shareholding | |
30 Mar 2001 | 07:30 AM | Regulatory Application | |
26 Mar 2001 | 07:00 AM | Purchase of Own Securities | |
15 Mar 2001 | 07:00 AM | Purchase of Own Securities | |
14 Mar 2001 | 07:00 AM | Share RePurchase | |
09 Mar 2001 | 03:14 PM | Re Annual Report, etc. | |
09 Mar 2001 | 07:00 AM | Purchase of Own Securities | |
07 Mar 2001 | 07:00 AM | Purchase of Own Securities | |
01 Mar 2001 | 07:01 AM | Purchase of Own Securities | |
27 Feb 2001 | 07:01 AM | Purchase of Own Securities | |
26 Feb 2001 | 04:00 PM | Holding in Company | |
22 Feb 2001 | 07:00 AM | Purchase of Own Securities | |
21 Feb 2001 | 07:01 AM | Regulatory Approval | |
20 Feb 2001 | 06:23 PM | Dividend | |
20 Feb 2001 | 09:00 AM | Patent Court Ruling Upheld | |
12 Feb 2001 | 07:00 AM | Purchase of Own Securities | |
09 Feb 2001 | 07:00 AM | Purchase of Own Securities | |
08 Feb 2001 | 07:07 AM | Dividend | |
08 Feb 2001 | 07:01 AM | Final Results Part 2 of 2 | |
08 Feb 2001 | 07:01 AM | Final Results Part 1 of 2 | |
07 Feb 2001 | 04:00 PM | Holding in Company | |
07 Feb 2001 | 09:00 AM | Notice of Results | |
06 Feb 2001 | 05:00 PM | Director Shareholding | |
01 Feb 2001 | 12:52 PM | Re Agreement | |
19 Jan 2001 | 01:30 PM | Disposal | |
09 Jan 2001 | 09:13 AM | Stmnt re Genpharm Inc | |
04 Jan 2001 | 10:00 AM | Stmnt re MRP Approval | |
22 Dec 2000 | 10:30 AM | Director Shareholding | |
19 Dec 2000 | 02:00 PM | Court Ruling | |
12 Dec 2000 | 09:45 AM | Result of Meeting - Part 2 | |
12 Dec 2000 | 09:45 AM | Result of Meeting - Part 1 | |
11 Dec 2000 | 09:15 AM | Notice of Meeting | |
17 Nov 2000 | 04:38 PM | Director Shareholding | |
17 Nov 2000 | 04:38 PM | Director Shareholding | |
17 Nov 2000 | 01:15 PM | Court Ruling | |
15 Nov 2000 | 04:00 PM | Director Shareholding | |
13 Nov 2000 | 11:02 AM | Re Directorate | |
13 Nov 2000 | 08:10 AM | Stmnt re Syngenta AG | |
13 Nov 2000 | 07:00 AM | Fthr reSyngentaGlobal Sec Off | |
02 Nov 2000 | 10:00 AM | Stmnt re FTC Approval | |
02 Nov 2000 | 07:30 AM | Syngenta Suppl. Prospectus | |
30 Oct 2000 | 12:00 PM | Stmnt re Divestment |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.